PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Category: Study Protocol

Child Adol Mental Disorders

Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain—Part II

by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada

November 1, 2019 No Comments

Drug Development

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

by Leslie Citrome, MD, MPH; Stephanie S. O’Malley, PhD; David

May 1, 2019 No Comments

The 30th Anniversary of PANSS Special Edition

Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome

November 1, 2017 No Comments

Assessment Tools

Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience

by Philip D. Harvey, PhD; Anzalee Khan, PhD; and Richard

November 1, 2017 No Comments

Assessment Tools

Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR

by Philip D. Harvey, PhD; Cynthia O. Siu, PhD; and

November 1, 2017 No Comments

Assessment Tools

Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency

by Anzalee Khan, PhD; Lora Liharska, MS; Philip D. Harvey,

November 1, 2017 No Comments

Assessment Tools

Disparity between General Symptom Relief and Remission Criteria in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor Item Response Theory Model

by Ariana E. Anderson, PhD; Steven P. Reise, PhD; Stephen

November 1, 2017 No Comments

Assessment Tools

Understanding Antipsychotic Drug Treatment Effects: A Novel Method to Reduce Pseudospecificity of the Positive and Negative Syndrome Scale (PANSS) Factors

by Seth C. Hopkins, PhD; Ajay Ogirala, PhD, Antony Loebel,

November 1, 2017 No Comments

Assessment Tools

Sensitivity of the Positive and Negative Syndrome Scale (PANSS) in Detecting Treatment Effects via Network Analysis

by Farnaz Zamani Esfahlani, MS; Hiroki Sayama, DSc; Katherine Frost

November 1, 2017 No Comments

Assessment Tools

Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other Assessments Based on the Simplified Negative and Positive Symptoms Interview (SNAPSI)

by Søren D. Østergaard, MD, PhD; Mark G. A. Opler,

November 1, 2017 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

©2024 Matrix Medical Communications copyright all right reserved.